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The extent and progression of exposure to feline infectious peritonitis (FIP) virus in the cheetah, Acinonyx
jubatus, was monitored by a world-wide serological survey with indirect fluorescent antibody titers to
coronavirus. The indirect fluorescent antibody assay was validated by Western blots, which showed that all
indirect fluorescent antibody-positive cheetah sera detected both domestic cat and cheetah coronavirus
structural proteins. There was a poor correlation between indirect fluorescent antibody results and the
presence of coronaviruslike particles in cheetah feces, suggesting that electron microscopic detection of shed
particles may not be an easily interpreted diagnostic parameter for FIP disease. Low, but verifiable (by
Western blots [immunoblots]) antibody titers against coronavirus were detected in eight free-ranging cheetahs
from east Africa as well as from captive cheetahs throughout the world. Of 20 North American cheetah facilities
screened, 9 had cheetahs with measurable antibodies to feline coronavirus. Five facilities showed patterns of an
ongoing epizootic. Retrospective FIP virus titers of an FIP outbreak in a cheetah-breeding facility in Oregon
were monitored over a 5-year period and are interpreted here in terms of clinical disease progression. During
that outbreak the morbidity was over 90% and the mortality was 60%, far greater than any previously
reported epizootic of FIP in any cat species. Age of infection was a significant risk factor in this epizootic, with
infants (less than 3 months old) displaying signfficantly higher risk for mortality than subadults or adults.
Based upon these observations, empirical generalizations are drawn which address epidemiologic concerns for
cheetahs in the context of this lethal infectious agent.
Feline infectious peritonitis (FIP) is a fatal immune-medi-
ated disease of domestic cats that is a consequence of
infection by an immunogenic coronavirus, FIP virus (FIPV),
with a positive-stranded RNA genome. The epizootiology
and etiology of FIP are not well understood, despite consid-
erable study since the original description in 1963 (3, 10, 15,
37, 38). At least three clinical forms of disease are recog-
nized: (i) effusive or wet FIP, which is characterized by
fibrinous peritonitis or pleuritis and which is always fatal; (ii)
the noneffusive or dry form of FIP, which does not have the
fluid but which does have the fibrinous peritoneal deposition
and is also fatal; and (iii) a subclinical enteritis, which is mild
in terms of recognizable symptoms (27; J. E. Barlough and
C. A. Stoddart, in C. E. Greene, ed., Infectious Diseases of
the Dog and Cat, in press). In domestic cats the fatal form is
rare (ca. 1% of an infected colony will die), and the virus
seldom affects more than 10% of domestic cats in a group
even under the most severe conditions for disease (27).
Several FIPV isolates have been described, and they may
vary from extreme virulence and pathology to subclinical
outcomes (5, 21, 27, 28). The non-FIP forms of feline
* Corresponding author.
t Present address: TNO Primate Centre, 2280 HV Rijswijk, The
Netherlands.
t Present address: Department of Wildlife Fisheries Biology,
University of California at Davis, Davis, CA 95616.
coronavirus have been designated feline enteric coronavirus
(FECV) to distinguish them from immunologically related
but pathological FIPV isolates (20, 21, 27, 28, 36; Barlough
and Stoddart, in press).
Before 1982, serological evidence established that chee-
tahs (Acinonyx jubatus) were susceptible to infection by
feline coronaviruses (FIPV, FECV, and other related
strains), but no cases of clinical FIP were reported (1, 16).
Beginning in 1982, a devastating epizootic occurred in a
cheetah-breeding colony located at Wildlife Safari in Win-
ston, Oreg. (2, 6, 9, 31). What initially appeared as an acute
anorexia, jaundice, and enteritis in an adult cheetah resulted
in death from FIP and rapid viral transmission to other
resident cheetahs. Within 6 months, every cheetah in the
facility developed immunofluorescent antibodies to feline
coronavirus, ostensibly because of exposure to the fatal
FIPV that had afflicted the original cheetah (2, 9, 23). Over
the next 12 months, clinical signs (intermittent and chronic
diarrhea, chronic gingivitis, hepatic and renal disease,
weight loss, and depression) and morbidity were apparent in
over 90% of the cheetahs. Despite aggressive clinical ther-
apy, a total of 27 cheetahs died between 1983 and 1987 from
one or more of the following coronavirus-associated dis-
eases: fibrinous peritonitis, renal and hepatic disease, enteri-
tis and malabsorption syndrome, hemorrhagic gastroenteri-
tis, and FIP-associated kitten mortality complex. In the
same period, 18 cheetahs were exposed to the FIPV and
1964
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survived, thereby permitting an overall mortality estimate of
60%. Since the Oregon epizootic, and perhaps in some part
because of it, the understanding of the etiology of FIP in
cheetahs has become an important priority in discussions of
captive breeding and wildlife management strategies for the
species (8, 19). The inability to develop an effective vaccine
or treatment for FIP has made this virus a serious concern
that must be considered in programs designed to stabilize
and protect cheetah populations.
We present here an update on the extent and progress of
the Oregon FIP epizootic from 1982 through 1987 which
serves as an important model for interpreting immunological
data in other populations. In addition, we present a serologic
survey of the prevalence of feline coronavirus infection in
captive cheetahs from zoological facilities in North America,
Europe, East Africa, and South Africa plus a population
survey from free-ranging cheetahs of the Serengeti ecosys-
tem. The various feline coronavirus detection techniques,
including immunofluorescence, Western blots, and electron
microscopy, were compared, and the epizootical results
were interpreted in terms of management recommendations
for this severely threatened species.
MATERIALS AND METHODS
Serological assays. Serum samples were collected from 45
cheetahs at Wildlife Safari in Winston, Oreg., on a yearly
basis since 1982. In addition, serum samples were submitted
from 132 cheetahs held at 20 zoologic facilities throughout
the United States and Canada (18). Serum was also collected
from 101 cheetahs in Africa and Europe. There were two
sites in eastern Africa, one site in southern Africa, and one
site in Great Britain. Antibodies against the feline coronavi-
ruses were measured by an indirect fluorescent antibody
(IFA) assay with canine coronavirus (1-71 strain) as the
antigen substrate (2, 6, 9). Previous studies assessing feline
coronavirus antibody titers in serum from domestic cats and
cheetahs have shown that there is considerable antigenic
similarity when the substrate is prepared with either canine
coronavirus, transmissible gastroenteritis virus of swine, or
FIPV (16, 30). The substrate was prepared in Crandell feline
kidney (CrFK) cells set on microscope slides with an 8-well
Bellco template (Beilco, Vineland, N.J.). The slides were
fixed in chilled acetone for 10 min, air dried, and stored at
-20°C until serologic tests were run. Cheetahs with IFA
titers in serum of 1:25 and higher were considered seropos-
itive to feline coronavirus (6).
EM. Fecal samples from cheetahs located in facilities in
North America were processed and observed by electron
microscopy (EM) as previously described (33). Fecal sam-
ples were refrigerated during shipment to the laboratory and
stored at 4°C before analysis to avoid freezing, which can
alter virus morphology.
Western blots. The Western blot (immunoblot) analyses
were performed by the method of Towbin et al. (35). Briefly,
virus samples were treated with 2 x phosphate-buffered
saline and electrophoresed for 60 min at 200 V (constant
voltage) in 12% sodium dodecyl sulfate-polyacrylamide gels
in a Bio-Rad mini-gel apparatus (Bio-Rad Laboratories,
Richmond, Calif.) equilibrated for 30 min in 25 mM Tris-192
mM glycine-20% methanol (transfer buffer). Proteins were
transferred by electric charge to nitrocellulose paper
(Scheller & Schuell, Inc., Keene, N.H.) in a minitransfer
apparatus (Bio-Rad) in transfer buffer at 30 V (constant
voltage) overnight. Blots were disassembled and briefly
washed in TBS (20 mM Tris, 500 mM NaCl [pH 7.4]) for 10
min, blocked in 3% gelatin-TBS, and reacted with cheetah
or domestic cat sera to detect the presence of coronavirus
antibodies. After two 10-min washes, blots were immersed
in 1:100 dilution of anti-cat whole immunoglobulin G
(Kirkegaard and Perry Laboratories, Gaithersburg, Md.) in
1% gelatin-TBS for 60 min, washed twice, and reacted with
BCIP/NBT alkaline phosphatase substrate system (Kirke-
gaard and Perry Laboratories) for 15 min. Blots were scored
0 to 3 based on the intensity of bands identified at 205
kilodaltons (nucleocapsid) and 24 kilodaltons (membrane
proteins).
Viruses. Comparison of antigenic profiles identified by
seropositive cheetahs with seropositive domestic cats was
conducted by using four pathologic strains of domestic feline
coronavirus. The strains included FECV WSU 79-1683,
FIPV WSU 79-1146, FIPV NOR-15, and FIPV UCD-1 (5,
21, 27, 29). The cheetah coronavirus isolate AJUCV-1 (pre-
viously designated WSU 83-4497) was maintained in CrFK
cells as a persistent nonlytic infection (6, 7). Supernatants
from cells infected with the four feline coronavirus strains
and from cells persistently infected with WSU 83-4497 were
harvested and processed by differential centrifugation.
Briefly, FC-009 cells (courtesy of N. C. Pedersen) were
grown in Dulbecco minimal essential medium, and 10% fetal
bovine serum was used to propagate the four feline corona-
virus strains, which were inoculated at a multiplicity of
infection of approximately 0.1. The supernatant was har-
vested from flasks when 80 to 90% cytopathic effect was
obtained and stored at -20°C. After clarification at 800 x g
at 4°C for 20 min, the supernatant was carefully removed,
and the virus was pelleted at 16,500 rpm 4°C for 45 min.
Samples of 100x-concentrated virus were mixed with 2x
sample buffer and run on 12% sodium dodecyl sulfate-
polyacrylamide gels and stained with Coomassie blue to
quantify virus antigens.
RESULTS
An epizootic of FIP in captive cheetahs. The Wildlife Safari
in Winston, Oreg., began what was to become a highly
successful cheetah-breeding program in 1973. In May 1982,
two cheetahs, studbook (SB) numbers 79 and 80 (18), were
imported into the park. Within a few weeks SB79 developed
severe jaundice, depression, fever, and diarrhea and died in
late June of FIP (31). A retrospective survey of cheetah
serum collected from the facility's cheetahs before May 1982
revealed that none (of 25 tested) had circulating antibody
titers against coronavirus, based upon an IFA assay. Within
6 to 8 months, sera from every cheetah in the facility were
positive for antibodies to coronavirus, a result consistent
with dynamic highly contagious infection with FIPV.
A summary of the antibody titer progression of 45 chee-
tahs that became infected during the period from 1982
through 1988 is presented in Fig. 1. Figure la presents the
titers of cheetahs who succumbed to FIP-related disease (n
= 27), and Fig. lb presents the titers of cheetahs that
developed antibodies to coronavirus but did not die of frank
FIP as of June 1988 (n = 18). Preliminary reports of earlier
studies have been presented elsewhere (2, 9).
There are several important observations which emerge
from examination of Fig. 1. First, before May 1982 each
tested animal was seronegative (FIPV antibody titers, <25),
and after 6 months all cheetahs became seropositive. Sec-
ond, with time antibody titers in all cheetahs increased to
VOL. 64, 1990
 o
n
 January 12, 2016 by NO
VA SO
UTHEASTERN UNIV
http://jvi.asm.org/
D
ow
nloaded from
 
1966 HEENEY ET AL.
1982 1983 1984 1982 1983 1984
a F J O F J O F J O f J O F J O F J O
>1
I1
>1
I
>1
I
>1
1
1982 1983 1984
F J O F J O F J
--;-----; - - ; -~~~W r %F w ;w r w;% W-WWw %O-;
1600 _ 35 79 60 258
25
_t t/\
600
25 -
<25 195 25 2931 294
1600 _
400
<25 L.L ..fiI fI||'''''''' ___ _
1600
600
400
100
25
>1600
1600
400
100
25
_160
>16001600
400
100
25
295
t....
ft I
315
IL
F J F J O F J 0
1982 1983 1964
296
1...I
310
I
316
I
297
311
IX.
1L
317
306 388
i
I
I
F J F J F J F JO F J F J F J F J O F J 0
1982 1983 1964 1962 1963 1964 1962 1963 19
Date of Serum Collection
FIG. 1. Time course of FIP IFA titers in serum from cheetahs at Wildlife Safari, Winston, Oreg. Studbook numbers are from the North
American cheetah studbook (18). Arrows indicate dates of death. SB79 and SB80 were the two animals that arrived at the park with FIP titers.
(a) Animals that have died of FIP-related disease based upon necropsy diagnosis. (b) Animals that have been exposed acutely but recovered
and were without symptoms at the last sampling.
between 1:400 and 1:1,600. Third, there was often a modest
decrease in FIPV antibody titer in dying animals, presum-
ably as a consequence of immune suppression during later
disease stages. Fourth, there was no obvious difference in
the seroprevalence patterns in animals that succumbed to
FIPV and those that survived. Fifth, in surviving animals,
antibody titers tended to persist for several years, suggesting
a chronic infection with the FIPV which continually stimu-
lated the immune system of infected cheetahs. There were
certain exceptions to this pattern (e.g., SB319 and SB383),
but the more common scenario was persistence of apprecia-
ble antibody titers against coronavirus for a period of 4 to 6
years.
An important risk factor that would influence mortality
due to FIPV appears to be age at exposure (see reference 18
for dates of birth). Of the 45 cheetahs studied, 20 were
exposed as infants (less than 5 months old); of these, only 3
(15%) survived. The survival rate of 25 older cheetahs was
60%. The overall mortality related to FIPV exposure was
60%. The relative survival of infants exposed to FIPV was
significantly different from that for all cheetahs (X2 = 9.37; P
< 0.01).
Among the cheetahs which succumbed to FIP, the median
time from seroconversion to death was 7 to 12 months (Fig.
2). Three animals, SB258, SB259, and SB294, each survived
over 38 months before dying of FIP, but their FIPV antibody
titer patterns are perhaps illuminating. All three cheetahs
showed declining antibody titers in 1983 through 1984 (the
titer of SB259 dropped to c25 for two consecutive samples
in 1984), and thereafter the two tested animals developed
elevated titers in 1985 until their deaths in 1986 (Fig. la).
Since the three animals were housed in the same pens, their
parallel pattern may indicate an acute secondary infection or
possibly a common environmental change that caused acti-
vation of latent FIPV. The other surviving cheetahs have
lived for up to 5 years (Fig. 2b) without apparent symptoms.
Seroprevalence in captive and free-ranging cheetah popula-
tions. Coronavirus antibody titers from 101 cheetah serum
samples collected from four locations outside of the United
States are presented in Table 1. With the exceptions of sera
collected in the Serengeti from 25 free-ranging cheetahs (25),
the sera were from captive animals, although several of these
cheetahs in Africa were born in the wild. Low antibody titers
were detected in a few animals from each locale, but only
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FIG. 1-Continued.
two cheetahs (one from the Serengeti and one captive animal
in Kenya) had titers of 1:100 or greater. Low IFA titers
(1:25) were verified by Western blots (see below). With the
exception of these infrequent low titers, the overall titer
pattern in each of these locations resembles the Oregon
situation before 1982 (Table 1).
In the United States, the Oregon epizootic influenced the
cheetah species survival plan, organized by the American
Association of Zoological Parks and Aquariums, to recom-
mend periodic monitoring of captive cheetahs for coronavi-
rus titers. The distribution of feline coronavirus titers in
serum samples from 132 cheetahs held in 20 North American
facilities (zoos and wildlife reserves) is presented in Table 2.
Eight of the facilities provided samples of their colonies in
both 1986 and 1987 (1 through 8 in Table 2). Among these
facilities, there were two patterns that emerged: (i) those in
which all cheetahs were clearly seronegative over time
(facilities 1 through 4); and (ii) those in which cheetahs were
clearly seropositive in 1986 (facilities 5 through 8), with a
progression from low titers in a few animals to higher titers
in more animals. Like the experience at Wildlife Safari, the
FIPV appears to spread to other cheetahs in these facilities
and to proceed with increasing coronavirus titers. Interest-
ingly, animals in these four facilities did not exhibit clinical
symptoms of FIP, although FIP pathology has been ob-
served in two other North American facilities not monitored
serologically in our studies (19) as well as in two sites in
Europe and three facilities in Japan (Marker-Kraus et al.,
manuscript in preparation). The remaining surveyed institu-
tions only produced one-time samples, so the results were
less easily interpreted. However, cheetahs in facilities 9
through 15 produced low or no titers, similar to those from
DeWildt and Whipsnade, whereas facilities 16 through 20
maintained cheetahs with higher titers more reminiscent of
those at Wildlife Safari in the years after the FIP outbreak.
IFA titers do not correlate with EM screens for coronavi-
ruslike particles. Seventy-four fecal samples were submitted
from captive cheetah populations at 13 facilities in North
America for EM analysis. The overall prevalence of chee-
tahs with evidence of fecal coronaviruslike particles was
31% (21 of 68) (Table 2). Of the 21 cheetahs shedding
coronaviruslike particles in their feces, only 8 (38%) had
demonstrable serum IFA titers to coronavirus. The high
frequency of discordance between feline coronavirus anti-
bodies and the presence of fecal particles is difficult to
explain but could be the result of the occurrence of corona-
viruslike particles in the feces which are immunologically
distinct from the pathological FIPV.
Virus isolation was attempted by using CrFK cells on all
fecal samples in which particles were observed. None of
these attempts, however, was successful. Previous corona-
viral isolations from both domestic cats and cheetahs have
revealed a strong dependence upon tissue of origin, host cell
b
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FIG. 2. (a) Distribution of the time intervals between infection
with FIPV and death by FIP-related disease in cheetahs at Wildlife
Safari, Winston, Oreg. (b) Time of survival since FIPV infection in
surviving cheetahs.
system, and the presence of exogenous protease to enhance
viral replication (5-7, 20).
Western blot analyses. Serum samples (diluted 1:5, 1:10,
1:50, and 1:100) from 93 African cheetahs (Table 3) plus from
15 cheetahs from Wildlife Safari were screened by using
Western blots against four feline coronavirus strains (Fig. 3).
All IFA-positive animals, except one with a titer of 1:100,
detected coronavirus proteins of each FIPV isolate on West-
ern blots. The blot profile varied for each isolate, most
appreciably in the membrane (or matrix) protein region,
where a common 29-kilodalton band was detected in strains
FIPV WSU 79-1146, FIPV Nor-15, and FECV WSU 79-1683
but was faint or absent in the FIPV UCD-1 preparation. The
intensity of staining of each band was a function of antibody
titer, but there were also some noticeable differences and
similarities between individuals on different continents. For
example, the isolate from an East African cheetah (AJU 220)
showed a major 29-kilodalton band like that of the Nor-15
strain and had the same Western blot profile as the isolate
from one captive North American cheetah (AJU 87) but
differed from the isolate from another East African cheetah
(AJU 219) which failed to show the 29-kilodalton protein
(Fig. 3).
TABLE 1. Worldwide prevalence of cheetah
coronavirus exposure
No. of cheetahs with
Date serum coronavirus titersa of:Locationcoltecollected c25 25 100- 400- 1600
~25125 625 -1,0
DeWildt, South Africab 1982 49 3 0 0 0
Serengeti, East Africac 1985 17 7 1 0 0
Whipsnade, Englandd 1985 11 1 0 0 0
Kenya captive, East 1985 8 3 1 0 0
Africa
Wildlife Safari, Oreg. Before June 25 0 0 0 0
1982
June 1983 0 0 2 18 15
June 1985 0 1 5 7 3
a IFA titers are expressed as the reciprocal of the highest dilution of serum
resulting in positive immunofluorescence.
b DeWildt Cheetah Research Center, Transvaal, Republic of South Africa.
c Free-ranging animals collected in the Serengeti National Park and the
Ngorongora Conservation Reserve in Tanzania (25).
d Whipsnade Park, a preserve operated by the Zoological Society of
London.
The numbers of African cheetah serum samples that
detected antigens of the four isolates of domestic cat coro-
navirus are presented in Table 3. This table demonstrates the
highly conserved antigenic nature of the nucleoprotein that
was identified in most IFA-positive cheetah sera with all
domestic cat coronaviruses in this study. Less conserved
were the membrane antigens, which were recognized by 20
to 85% of the serum samples, depending upon the virus
isolate. These data suggest that African cheetahs have been
exposed to several immunologically different strains of coro-
naviruses.
Comparison of cheetah coronavirus isolate to domestic cat
coronaviruses. A feline coronavirus was isolated from a
cheetah from Oregon which perished from FIP (7). The
specificity of serum samples from several IFA-positive do-
mestic cats and cheetahs were tested by Western blotting for
reactivity to the cheetah isolate designated AJUCV-1 (8).
Both the cheetah and domestic cat sera detected nucleocap-
sid proteins of AJUCV-1, FIPV 79-1146, and FIPV UCD-1
(Fig. 4). Reactivity of the sera from both species to the
membrane protein was variable, indicating antigenic heter-
ogeneity within the viral populations that infect these ani-
mals.
DISCUSSION
We have presented a serological survey of the incidence
and pattern of exposure to feline coronavirus in captive and
free-ranging cheetahs in North America, Europe, and Af-
rica. In addition we have summarized the results of a
retrospective serum survey of the FIP epizootic that began
in 1982 at a cheetah-breeding facility in Winston, Oreg.
Because of the shortage of epidemiological studies of this
disease in cheetahs and in light of the danger of too-strict
extrapolation from disease progression in the domestic cat, it
seems important to understand the lessons of this epizootic
as a basis for interpreting incipient outbreaks in cheetah
populations in captivity and in their natural range.
The Oregon outbreak occurred with the arrival at the
facility in 1982 of an infected animal from another park.
Before 1982 all of the cheetahs in the park were coronavirus
seronegative. Within 8 months all cheetahs in the park
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TABLE 2. Feline coronavirus antibody titers and EM results in North American zoologic facilities in 1986 and 1987
No. of cheetahs with the following EM screen of feces
Serum result Total no. of coronavirus IFA titers (X10)
and facility no. Year cheetahs at facility N sti
-25 25 100-125 4004625 -1,600 no. tested % Positive
Seronegative
1 1986 10 9 0 0 0 0 0/9 0
1987 2 0 0 0 0 NDa
2 1986 14 7 0 0 0 0 1/8 13
1987 11 0 0 0 0 ND
3 1987 3 3 0 0 0 0 ND
4 1986 9 9 0 0 0 0 9/9 100
Seropositive
5 1986 4 3 1 0 0 0 3/3 100
1987 1 0 0 5 3 ND
6 1986 20 3 1 1 0 0 2/6 33
1987 7 6 2 0 6 ND
7 1986 5 2 1 0 1 1 3/5 60
1987 0 0 0 1 4 ND
8 1986 22 10 0 5 3 1 1/22 5
1987 39 17 5 5 9 3 ND
Indeterminant
9 1986 3 3 0 0 0 0
10 1986 5 5 0 0 0 0
11 1986 2 3 1 0 0 0 0/1 0
12 1987 1 1 0 0 0 0
13 1986 1 1 1 0 0 0 1/2 50
14 1986 17 1 0 0 0 0
15 1986 4 2 0 0 0 2 1/2 50
16 1986 2 0 2 0 0 0
17 1986 1 0 0 0 0 1 1/1 100
18 1986 5 0 0 0 2 3
19 1986 4 1 2 0 0 1
20 1986 7 0 0 0 1 0
a ND, Not determined.
seroconverted, and after 4 years 60% had died of FIP-related
disease. Age of infection was a significant risk factor, with
infants (0 to 5 months of age) being at greater risk. The
median time from seroconversion (as a marker of exposure)
TABLE 3. Western blot results comparing antigens of
four strains of feline coronavirus in reaction
with sera from 20 cheetahsa
No. positive (%) on
Feline Western blot ofb:
coronavirus Sequelae inisolonateru domestic cats Membrane Nucleo-
antigen protein
(29 kDa) (45 kDa)
WSU 79-1683 Enteritis, non-FIP; 17 (85) 19 (95)
(FECV) high morbidity, low
mortality
UCD-1 FIP dose-related viru- 4 (20) 18 (90)
(FIPV) lence; high morbid-
ity, high mortality
WSU 79-1146 FIP very virulent, low 13 (65) 20 (100)
(FIPV) dose; high morbidity,
high mortality
NOR-15 FIP very virulent, low 14 (70) 18 (90)
(prototype dose; high morbidity,
strain) high mortality
a Twenty cheetah sera (Table 1) with coronavirus IFA titers of >25.
b Results indicate numbers and percentages of cheetah sera which identified
the nucleoprotein and membrane antigens in Fig. 3.
to death was 6 to 12 months. Interestingly, there was no
obvious difference between the temporal pattern of feline
coronavirus serum antibody titers in cheetahs who died
versus those who survived (compare Fig. la and b).
The reasons why some cheetahs survived while others
perished are not clear, but, based on precedence from other
coronavirus and retroviral epizootics, there are three possi-
ble explanations (22, 24, 36). First, there is genetic variation
in virus isolates that produce different clinical results. This
seems to be the case in the domestic cat viruses, which range
from extremely virulent to subclinical (Table 3). Neverthe-
less, despite the isolation of clinically distinct domestic cat
coronaviruses, it has not been possible to develop type-
specific immunological reagents that discriminate between
them (11-14). There is currently no direct evidence for
functional heterogeneity of cheetah coronaviruses; however,
the discordance of coronaviruslike particles detected by EM
and the results of IFA and Western blot analyses (Table 2) is
consistent with appreciable antigenic diversity among chee-
tah coronaviruses. Second, there could be genetic differ-
ences in the host cheetahs that influence the pathology. This
is possible despite our earlier observation of the reduced
genetic diversity of cheetahs (23-26), since those results
showed reduced (10 to 100-fold) diversity but not complete
homozygosity at all loci. In fact, we have observed limited
heterozygosity in cheetahs by using molecular clones of one
gene involved in immune surveillance, the major histocom-
patibility complex (40a). Third, FIP pathology could involve
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FIG. 3. Western blot analysis of coronavirus antigens with selected cheetah sera. Four feline coronavirus strains, FIPV NOR-15, FECV
WSU 79-1683, FIPV UCD-1, and WSU FIPV 79-1146 (Table 3), were reacted with eight cheetah serum samples with IFA titers ranging from
1:25 to 1:1,600. Cheetahs AJU 84, 87, 88, and 89 were from Wildlife Safari; AJU 219 and 220 were captive animals in Kenya; and AJU 30
and 31 were from De Wildt Cheetah Research Center in South Africa. The molecular weight markers are listed on the left, and the main
coronaviral protein regions are listed on the right.
a cofactor such as a secondary synergistic virus or possibly
a stochastic (somatic or environmental) event to cause
pathology. For example, FIP has been suggested to progress
more rapidly and with more serious consequences in cats
concurrently infected with feline leukemia virus (27) or with
feline immunodeficiency virus (40).
In hopes of resolving some of these possibilities, we have
used three different methods for detecting feline coronavirus
in cheetahs: IFA assay, Western blots, and EM screening for
coronaviruslike particles in feces. The IFA method seems
rather verifiable with clinical disease, based upon the Oregon
epizootic and disease outbreaks in several other facilities
Virus Strain
IFA Titer
MW
205 k --
45 k -
29 k
Species
83-4497
U) 0c n
V4
V A V
10
td
Cat Cheetah
79-1146
c)
0 0)LO 0 O)0
v A v
(19). Further, the IFA assay and Western blots show excel-
lent correlation insofar as every IFA-negative serum was
also negative on Western blots and all IFA-positive sera
detected FIPV nucleoproteins, although there was some
variation in detection of the membrane protein. Notable
shifts in the molecular weight of the nucleoproteins observed
here (Fig. 3 and 4) may represent strain variations between
viral isolates but more likely reflect developmental process-
ing of nucleocapsid proteins previously reported for feline
coronavirus (36).
There was not a good correlation with the EM detection of
fecal coronaviruslike particles and the IFA assay. It is
UCD-1
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FIG. 4. Western blot analysis of coronavirus antigens with selected domestic cat (D. cat) and cheetah sera. One cheetah coronavirus
strain, AJUCV-1 (WSU 83-4497), and two feline coronavirus strains, FIPV WSU 79-1146 and FIPV UCD-1, were reacted with sera with IFA
titers ranging from negative (<1:25) to positive (>1:25 to 1:16,000). The molecular weight markers are listed on the left, and the main
coronaviral protein regions are listed on the right.
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possible that this discordance would result from an acquired
infection before the development of an immune response.
Based upon the well-known existence of antigenic drift in
RNA viruses (41) and in coronaviruses (4, 17, 32, 39), it is
also likely that these particles may represent viruses that are
morphologically similar to but antigenically distinct from the
recognized strains of FIPV and FECV (20, 36). The discor-
dance between IFA serology results versus EM coronavirus
screening in cheetahs makes it difficult to interpret the EM
results as a diagnostic parameter for cheetahs.
The observations of the Oregon outbreak plus the results
of the IFA serum survey for free-ranging and captive chee-
tahs have suggested the following conclusions, which we
recommend for consideration of this pathogen in managed
cheetah populations.
(i) Pathological FIPV is highly infectious and spreads
rapidly among cheetahs when physical contact occurs, prob-
ably through exchange of excretory material and/or secre-
tions (34).
(ii) Pathological FIP is a dynamic disease process that is
correlated with continuous, measurable, and often increas-
ing titers to feline coronavirus.
(iii) Occasional low antibody titers have been observed in
several populations, including free-ranging animals (Table 1
and 2), which could signal an incipient disease epizootic but
may also reflect infection with a nonpathological but anti-
genically related coronavirus. The confirmation of a clinical
epizootic would require time points showing increasing
numbers and higher titers (as in facilities 5 through 8) plus
morbidity. Facilities with increasing titers but no disease
(facilities 5 through 8 in Table 2) may prove particularly
interesting, because they raise the possibility of clinical
heterogeneity of virus isolates between different facilities.
Long-term monitoring of these facilities to confirm this
hypothesis is desirable.
The present results indicate that coronavirus infections
are occurring in captive and free-ranging cheetah popula-
tions, as has been reported for domestic cats (1, 16, 27). The
factors that appear to be important with the occurrence of
FIP in a population of cats are a combination of a virulent
strain of virus together with a susceptible group of cats (1,
16, 27). The cheetah has been reported as being unusually
vulnerable to FIPV, based on epizootics that have occurred
in the United States, Canada, Ireland, Namibia-Southwest
Africa, The Netherlands, and Japan (9, 18, 19, 23). The
results of the study reported herein indicated that the expo-
sure rate to feline coronavirus, or a closely related corona-
virus, is similar to that reported for domestic cats. Until
further information is reported concerning coronavirus in-
fections in exotic cats, the management of cheetahs should
follow basic guidelines for control of infectious diseases,
such as segregation of seropositive animals from seronega-
tive animals, quarantine before and after arrival at the
zoologic facility, and regular monitoring by serology (8).
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